Free Trial

Soleno Therapeutics (SLNO) Short Interest Ratio & Short Volume

Soleno Therapeutics logo
$44.11 -1.69 (-3.69%)
As of 12:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Soleno Therapeutics Short Interest Data

Soleno Therapeutics (SLNO) has a short interest of 4.54 million shares, representing 14.43% of the float (the number of shares available for trading by the public). This marks a 4.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 438,222 shares to cover all short positions.

Current Short Interest
4,540,000 shares
Previous Short Interest
4,350,000 shares
Change Vs. Previous Month
+4.37%
Dollar Volume Sold Short
$223.23 million
Short Interest Ratio
8.2 Days to Cover
Last Record Date
February 15, 2025
Outstanding Shares
43,117,000 shares
Float Size
31,470,000 shares
Short Percent of Float
14.43%
Today's Trading Volume
150,559 shares
Average Trading Volume
438,222 shares
Today's Volume Vs. Average
34%
Short Selling Soleno Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Soleno Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SLNO Short Interest Over Time

SLNO Days to Cover Over Time

SLNO Percentage of Float Shorted Over Time

Soleno Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20254,540,000 shares $223.23 million +4.4%14.4%8.2 $49.17
1/31/20254,350,000 shares $218.50 million -8.0%13.4%7.6 $50.23
1/15/20254,730,000 shares $229.74 million +3.1%14.5%8 $48.57
12/31/20244,590,000 shares $206.32 million +3.6%14.3%6.6 $44.95
12/15/20244,430,000 shares $206.93 million -2.9%13.8%6.5 $46.71
11/30/20244,560,000 shares $240.36 million -3.8%14.2%6.9 $52.71
11/15/20244,740,000 shares $245.53 million -23.2%14.8%7.2 $51.80
10/31/20246,170,000 shares $339.72 million +8.1%20.1%9.8 $55.06
10/15/20245,710,000 shares $309.20 million +15.1%20.6%9.5 $54.15
9/30/20244,960,000 shares $250.43 million +6.4%19.1%9.1 $50.49
9/15/20244,660,000 shares $246.23 million +3.8%18.0%8.9 $52.84
8/31/20244,490,000 shares $219.79 million +13.1%18.2%8.6 $48.95
8/15/20243,970,000 shares $200.33 million +0.3%16.9%8.4 $50.46
7/31/20243,960,000 shares $190.99 million -0.8%17.5%8.7 $48.23
7/15/20243,990,000 shares $200.34 million +13.7%18.7%7.7 $50.21
6/30/20243,510,000 shares $143.21 million +4.5%15.6%6.9 $40.80
6/15/20243,360,000 shares $142.50 million -1.2%15.0%7.7 $42.41
5/31/20243,400,000 shares $143.07 million +6.9%16.0%8.3 $42.08
5/15/20243,180,000 shares $143.77 million -6.7%15.0%7.4 $45.21
4/30/20243,410,000 shares $152.29 million +10.0%16.9%8.6 $44.66
4/15/20243,100,000 shares $119.41 million +12.3%15.7%10.2 $38.52
3/31/20242,760,000 shares $118.13 million +20.0%14.6%9 $42.80
3/15/20242,300,000 shares $99.96 million +36.9%12.2%7.8 $43.46
2/29/20241,680,000 shares $81.18 million +11.3%9.5%4.9 $48.32
2/15/20241,510,000 shares $70.17 million -0.7%8.5%4.8 $46.47
1/31/20241,520,000 shares $70.45 million +8.6%8.4%4.7 $46.35
1/15/20241,400,000 shares $58.51 million +4.5%7.8%4.4 $41.79
12/31/20231,340,000 shares $53.94 million +77.0%7.3%4 $40.25
12/15/2023756,900 shares $28.68 million +10.8%4.1%0.6 $37.89
11/30/2023683,300 shares $20.34 million +17.9%3.9%0.6 $29.76
11/15/2023579,500 shares $13.62 million -15.0%3.3%0.5 $23.51
10/31/2023682,000 shares $16.27 million +4.8%4.2%0.6 $23.85
10/15/2023650,500 shares $15.77 million -58.6%4.0%0.6 $24.25
9/30/20231,570,000 shares $46.33 million +683.0%15.7%1.5 $29.51
9/15/2023200,500 shares $982,450.00 +151.9%2.5%0.3 $4.90
8/31/202379,600 shares $389,244.00 -3.2%1.0%1.4 $4.89
8/15/202382,200 shares $371,544.00 +13.7%1.1%1.3 $4.52
7/31/202372,300 shares $368,730.00 -12.8%1.2%0.7 $5.10
7/15/202382,900 shares $446,002.00 +14.0%1.3%0.8 $5.38
6/30/202372,700 shares $311,883.00 -19.1%1.2%0.7 $4.29
Buy NVDA Now? (Ad)

After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chipmaker has struggled this year, facing increased competition and regulatory pressure.

For all the details - including the name and ticker of the #1 AI stock to buy instead of NVDA, click
6/15/202389,900 shares $449,500.00 -9.1%1.4%0.8 $5.00
5/31/202398,900 shares $521,203.00 +39.3%1.6%1 $5.27
5/15/202371,000 shares $298,555.00 +14.7%1.3%0.8 $4.21
4/30/202361,900 shares $208,603.00 -42.8%1.4%1.3 $3.37
4/15/2023108,200 shares $349,486.00 +27.6%1.9%1.7 $3.23
3/31/202384,800 shares $181,472.00 -7.3%1.5%1.1 $2.14
3/15/202391,500 shares $187,575.00 -16.1%1.6%0.3 $2.05
2/28/2023109,000 shares $221,270.00 -1.0%1.9%0.1 $2.03
2/15/2023110,100 shares $214,695.00 -40.3%2.5%0.1 $1.95
1/31/2023184,300 shares $536,313.00 -30.6%4.1%0.1 $2.91
1/15/2023265,400 shares $631,652.00 -55.1%6.0%0.1 $2.38
12/30/2022590,900 shares $1.17 million +498.1%13.3%0.3 $1.98
12/15/202298,800 shares $88,129.60 +14.8%2.2%0.1 $0.89
11/30/202286,100 shares $92,988.00 +65.3%1.9%1.3 $1.08
11/15/202252,100 shares $56,789.00 +10.2%1.2%0.5 $1.09
10/31/202247,300 shares $46,827.00 +65.4%1.1%0.5 $0.99
10/15/202228,600 shares $38,038.00 -53.0%0.7%0.3 $1.33
9/30/202260,900 shares $101,703.00 +13.8%1.4%0.5 $1.67
9/15/202253,500 shares $115,025.00 +21.6%1.3%0.4 $2.15
8/31/202244,000 shares $96,800.00 -94.5%1.0%0.3 $2.20
8/15/2022799,600 shares $153,923.00 -31.7%1.3%0.4 $0.19
7/31/20221,170,000 shares $200,070.00 +65.0%N/A0.6 $0.17
7/15/2022709,300 shares $130,936.78 -14.3%N/A0.4 $0.18
6/30/2022827,600 shares $153,106.00 +140.2%N/A0.6 $0.19
6/15/2022344,500 shares $56,498.00 +12.3%N/A0.2 $0.16
5/31/2022306,800 shares $49,486.84 +37.2%N/A0.3 $0.16
5/15/2022223,700 shares $37,760.56 -21.1%N/A0.3 $0.17
4/30/2022283,400 shares $56,680.00 -25.5%0.4%0.4 $0.20
4/15/2022380,300 shares $82,753.28 -36.8%0.5%0.6 $0.22
3/31/2022601,400 shares $134,112.20 +19.7%0.8%1.1 $0.22
3/15/2022502,600 shares $136,204.60 -9.4%0.9%2.1 $0.27
2/28/2022554,700 shares $179,334.51 -2.6%1.0%2.4 $0.32
2/15/2022569,600 shares $214,739.20 +11.0%1.1%2.4 $0.38
1/31/2022513,200 shares $182,186.00 +0.1%1.0%2 $0.36
1/15/2022512,800 shares $215,376.00 -28.9%0.9%1.9 $0.42
12/31/2021721,000 shares $295,610.00 +18.3%1.3%2.8 $0.41
12/15/2021609,500 shares $329,739.50 -3.7%1.1%2.6 $0.54
11/30/2021633,200 shares $413,226.32 -55.1%1.2%2.4 $0.65
11/15/20211,410,000 shares $1.09 million -4.7%2.6%4.5 $0.78
10/29/20211,480,000 shares $1.10 million +16.5%2.7%4.5 $0.74
10/15/20211,270,000 shares $1.06 million -2.3%2.3%3.4 $0.83
9/30/20211,300,000 shares $1.20 million -11.0%2.4%3.2 $0.92
9/15/20211,460,000 shares $1.32 million -15.1%2.7%2.3 $0.91
8/31/20211,720,000 shares $1.57 million -10.9%3.2%2.3 $0.91
8/13/20211,930,000 shares $1.69 million -2.0%3.6%0.7 $0.88
7/30/20211,970,000 shares $1.79 million -14.7%3.6%0.7 $0.91
7/15/20212,310,000 shares $2.24 million -4.9%4.4%0.8 $0.97
6/30/20212,430,000 shares $2.77 million -46.1%4.6%0.8 $1.14
6/15/20214,510,000 shares $5.01 million +18.7%8.6%1.5 $1.11
5/28/20213,800,000 shares $3.91 million +36.2%7.3%1.1 $1.03
Buy NVDA Now? (Ad)

After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chipmaker has struggled this year, facing increased competition and regulatory pressure.

For all the details - including the name and ticker of the #1 AI stock to buy instead of NVDA, click
5/14/20212,790,000 shares $2.70 million -0.4%N/A1.4 $0.97
4/30/20212,800,000 shares $3.44 million +17.2%N/A1.4 $1.23
4/15/20212,390,000 shares $2.92 million -2.5%N/A1.2 $1.22
3/31/20212,450,000 shares $3.11 million +41.6%N/A1.4 $1.27
3/15/20211,730,000 shares $2.66 million +125.5%N/A1.2 $1.54
2/26/2021767,300 shares $1.94 million -0.9%N/A1.1 $2.53
2/12/2021774,300 shares $2.18 million -23.3%N/A2.5 $2.82
1/29/20211,010,000 shares $2.00 million +10.3%N/A3.5 $1.98
1/15/2021916,100 shares $2.00 million -7.9%N/A3.4 $2.18
12/31/2020994,300 shares $1.93 million +0.3%N/A3.6 $1.94
12/15/2020991,100 shares $1.84 million -1.9%N/A2.4 $1.86
11/30/20201,010,000 shares $1.94 million -2.9%N/A2 $1.92
11/15/20201,040,000 shares $2.14 million No ChangeN/A1.9 $2.06
10/30/20201,040,000 shares $1.67 million -21.8%N/A1.7 $1.61
10/15/20201,330,000 shares $2.65 million -17.4%N/A2.1 $1.99
9/30/20201,610,000 shares $4.04 million +15.8%N/A2.4 $2.51
9/15/20201,390,000 shares $2.95 million -10.3%N/A1.7 $2.12
8/31/20201,550,000 shares $3.32 million -13.9%N/A1.7 $2.14
8/14/20201,800,000 shares $3.37 million -11.3%N/A1.7 $1.87
7/31/20202,030,000 shares $3.49 million -21.6%N/A2 $1.72
7/15/20202,590,000 shares $4.71 million -8.5%N/A2.6 $1.82
6/30/20202,830,000 shares $6.28 million +56.4%15.4%3.1 $2.22
6/15/20201,810,000 shares $3.55 million +195.8%7.0%2.8 $1.96
5/29/2020612,000 shares $2.18 million +44.6%2.5%1.5 $3.56
5/15/2020423,200 shares $1.40 million +195.7%1.8%2.8 $3.31
4/30/2020143,100 shares $440,748.00 +44.7%0.6%1.1 $3.08
4/15/202098,900 shares $305,601.00 -13.4%0.4%0.8 $3.09
3/31/2020114,200 shares $336,890.00 +23.5%0.4%0.7 $2.95
3/13/202092,500 shares $285,825.00 -22.3%0.3%0.7 $3.09

SLNO Short Interest - Frequently Asked Questions

What is Soleno Therapeutics' current short interest?

Short interest is the volume of Soleno Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 4,540,000 shares of SLNO short. 14.43% of Soleno Therapeutics' shares are currently sold short. Learn More on Soleno Therapeutics' current short interest.

What is a good short interest ratio for Soleno Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLNO shares currently have a short interest ratio of 8.0. Learn More on Soleno Therapeutics's short interest ratio.

Which institutional investors are shorting Soleno Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Soleno Therapeutics: Jefferies Financial Group Inc., Wolverine Trading LLC, Millennium Management LLC, Jefferies Financial Group Inc., Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Cantor Fitzgerald L. P., Balyasny Asset Management L.P., Jane Street Group LLC, Boothbay Fund Management LLC, Diadema Partners LP, HAP Trading LLC, Concourse Financial Group Securities Inc., JPMorgan Chase & Co., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Soleno Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.43% of Soleno Therapeutics' floating shares are currently sold short.

Is Soleno Therapeutics' short interest increasing or decreasing?

Soleno Therapeutics saw a increase in short interest in February. As of February 15th, there was short interest totaling 4,540,000 shares, an increase of 4.4% from the previous total of 4,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Soleno Therapeutics' float size?

Soleno Therapeutics currently has issued a total of 43,117,000 shares. Some of Soleno Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Soleno Therapeutics currently has a public float of 31,470,000 shares.

How does Soleno Therapeutics' short interest compare to its competitors?

14.43% of Soleno Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Soleno Therapeutics: Glaukos Co. (6.74%), Stevanato Group S.p.A. (7.24%), Bausch + Lomb Co. (3.36%), Inspire Medical Systems, Inc. (10.19%), Inari Medical, Inc. (4.24%), iRhythm Technologies, Inc. (8.46%), Envista Holdings Co. (5.74%), PROCEPT BioRobotics Co. (11.02%), LivaNova PLC (3.58%), TransMedics Group, Inc. (34.47%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

What does it mean to sell short Soleno Therapeutics stock?

Short selling SLNO is an investing strategy that aims to generate trading profit from Soleno Therapeutics as its price is falling. SLNO shares are trading down $1.69 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Soleno Therapeutics?

A short squeeze for Soleno Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLNO, which in turn drives the price of the stock up even further.

How often is Soleno Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLNO, twice per month. The most recent reporting period available is February, 15 2025.




This page (NASDAQ:SLNO) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners